NIH abruptly paused SBIR and STTR activity, creating uncertainty for applicants who now require strategy, preparation, and airtight compliance more than ever.


NIH abruptly paused SBIR and STTR activity, creating uncertainty for applicants who now require strategy, preparation, and airtight compliance more than ever.

Assembling a team with the right blend of expertise, leadership, and collaborative partnerships can significantly strengthen your proposal.

For startups pursuing non-dilutive funding, the SBIR/STTR programs offer a critical pathway to advance research and development while preserving ownership.

The government shutdown and SBIR/STTR expiration pause federal innovation funding, but prepared companies can emerge stronger when programs resume.

Customer discovery plays a pivotal role in crafting a credible and compelling SBIR/STTR application, especially when it comes to strengthening your commercialization plan.

Receiving a rejection after submitting an SBIR/STTR proposal can be disheartening, but it doesn’t have to be the end of your funding journey.

A critical factor in crafting a successful SBIR/STTR application is ensuring that your proposal aligns with the specific priorities and goals of the funding agency.

Securing non-dilutive funding can be a transformative opportunity for startups, providing the financial support needed to develop and commercialize innovative solutions without giving up equity.

Join our free Q&A sessions with Christine E.B. Howard, CEO of EB Howard Consulting! 🎤🤝 Gain expert advice, industry insights, and practical solutions. 🌟 Don’t miss out—sign up now! 🚀

Non-dilutive funding has been instrumental in the growth of numerous startups, enabling them to advance their innovations without relinquishing equity. Here are some real-life success stories from our clients.